Preliminary Considerations from the 2nd Phase of Experiments at the SIET/SWAM Facility

Severe accident codes study the thermo-hydraulics of the suppression chamber with a limited numbers of nodes, generally solving mass and energy equations and assuming perfect mixing conditions. In a long station black out the effect of the sparger’s design might create local phenomena (e.g. stratification, hot-spots) which are hardly predicted by the current practices, resulting in mispredictions of the containment pressure evolution. In order to understand the effect of the sparger geometry, steam mass flux, water sub-cooling and air concentration the SWAM facility (Steam Water Air Mixing) at the SIET laboratory was employed performing around twenty different experiments, in conditions close to what is expected during the Fukushima Daiichi accident. The test facility (poll and pipes) is built with polycarbonate (transparent material) to ease the acquisition of the standard and high-speed cameras. Vertically distributed thermocouples and high-frequency pressure measurements are employed to obtain quantitative values for phenomena investigation and future CFD validations. It was shown that experiments with pure steam and relatively large diameter holes induce chugging that enhances mixing in the pool. Once chugging ceases, because of the reduced sub-cooling, a hot water layer is created in the upper part of the pool. The presence of air in the pipe induces large stratification from the condition of large subcooling because of the limited mixing introduced in the region below the pipe mouth

Bulk and surface-sensitive high-resolution photoemission study of Mott-Hubbard systems SrVO3_3 and CaVO3_3

We study the electronic structure of Mott-Hubbard systems SrVO$_{3}$ and CaVO$_3$ with bulk and surface-sensitive high-resolution photoemission spectroscopy (PES), using a VUV laser, synchrotron radiation and a discharge lamp ($h\nu$ = 7 - 21 eV). A systematic suppression of the density of states (DOS) within $\sim$ 0.2 eV of the Fermi level ($E_F$) is found on decreasing photon energy i.e. on increasing bulk sensitivity. The coherent band in SrVO$_{3}$ and CaVO$_3$ is shown to consist of surface and bulk derived features, separated in energy. The stronger distortion on surface of CaVO$_{3}$ compared to SrVO$_{3}$ leads to higher surface metallicity in the coherent DOS at $E_F$, consistent with recent theory.Comment: 4 pages 5 figures (including 2 auxiliary figures); A complete analysis of the spectra based on the surface and bulk analysis shows in auxiliary figures Fig. A1 and A

No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations.

published_or_final_versio

Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels

Background/aim: To examine the risks for hepatocellular carcinoma (HCC) with respect to hepatitis B virus (HBV) genotypes, specific viral mutations (MT), serum HBV DNA levels, and cirrhosis. Methods: HBV genotypes, 1653/1753/core promoter (CP)/precore MT and HBV DNA levels were determined in 248 HBV patients with HCC and 248 HBV controls. Results: Genotype C, CP-MT, T1653, HBV DNA levels ≥4 log 10 copies/ml and cirrhosis had a higher risk for HCC compared to patients with genotype B (p = 0.001, OR 1.9), CP wild-type (WT) (p<0.001, OR 4.1), C1653 (p = 0.028, OR 2.4), HBV DNA <4 log 10 copies/ml (p = 0.003, OR 2.1) and without cirrhosis (p<0.001, OR 4.0) respectively. Multivariate analysis showed that CP-MT, T1653, HBV DNA ≥4 log 10 copies/ml and cirrhosis were independent factors for HCC (all p<0.05). A receiver operating characteristics curve showed no cut-off HBV DNA level associated with minimal chance of HCC. Patients with CP-MT and cirrhosis had a 22.2-fold increased risk of HCC compared to patients with CP-WT and without cirrhosis. Patients with CP-MT and HBV DNA levels ≥4 log 10 copies/ml had a 7.2-fold increased risk of HCC compared to patients with CP-WT and HBV DNA levels <4 log 10 copies/ml. Patients with CP-MT and T1653 had a 9.9-fold increased risk of HCC compared to patients with wild-type for both regions. Conclusions: CP-MT, T1653, HBV DNA levels ≥4 log 10 copies/ml and cirrhosis are independent factors for development of HCC. The risks increased substantially in patients having these factors in combination.published_or_final_versio

New susceptibility and resistance HLA-DP alleles to HBV-related diseases identified by a trans-ethnic association study in Asia

Previous studies have revealed the association between SNPs located on human leukocyte antigen (HLA) class II genes, including HLA-DP and HLA-DQ, and chronic hepatitis B virus (HBV) infection, mainly in Asian populations. HLA-DP alleles or haplotypes associated with chronic HBV infection or disease progression have not been fully identified in Asian populations. We performed trans-ethnic association analyses of HLA-DPA1, HLA-DPB1 alleles and haplotypes with hepatitis B virus infection and disease progression among Asian populations comprising Japanese, Korean, Hong Kong, and Thai subjects. To assess the association between HLA-DP and chronic HBV infection and disease progression, we conducted high-resolution (4-digit) HLA-DPA1 and HLA-DPB1 genotyping in a total of 3,167 samples, including HBV patients, HBV-resolved individuals and healthy controls. Trans-ethnic association analyses among Asian populations identified a new risk allele HLA-DPB1*09 ratio 01 (P = 1.36 x 10(-6); OR= 1.97; 95% CI, 1.50-2.59) and a new protective allele DPB1*02 ratio 01 (P = 5.22 x 10(-6); OR = 0.68; 95% CI, 0.58-0.81) to chronic HBV infection, in addition to the previously reported alleles. Moreover, DPB1*02 ratio 01 was also associated with a decreased risk of disease progression in chronic HBV patients among Asian populations (P = 1.55 x 10(-7); OR = 0.50; 95% CI, 0.39-0.65). Trans-ethnic association analyses identified Asian-specific associations of HLA-DP alleles and haplotypes with HBV infection or disease progression. The present findings will serve as a base for future functional studies of HLA-DP molecules in order to understand the pathogenesis of HBV infection and the development of hepatocellular carcinoma.published_or_final_versio

NS5A Resistance-Associated Substitutions in Patients with Genotype 1 Hepatitis C Virus:Prevalence and Effect on Treatment Outcome

Background & Aims The efficacy of NS5A inhibitors for the treatment of patients chronically infected with hepatitis C virus (HCV) can be affected by the presence of NS5A resistance-associated substitutions (RASs). We analyzed data from 35 phase I, II, and III studies in 22 countries to determine the pretreatment prevalence of various NS5A RASs, and their effect on outcomes of treatment with ledipasvir-sofosbuvir in patients with genotype 1 HCV. Methods NS5A gene deep sequencing analysis was performed on samples from 5397 patients in Gilead clinical trials. The effect of baseline RASs on sustained virologic response (SVR) rates was assessed in the 1765 patients treated with regimens containing ledipasvir-sofosbuvir. Results Using a 15% cut-off, pretreatment NS5A and ledipasvir-specific RASs were detected in 13% and 8% of genotype 1a patients, respectively, and in 18% and 16% of patients with genotype 1b. Among genotype 1a treatment-naïve patients, SVR rates were 91% (42/46) vs. 99% (539/546) for those with and without ledipasvir-specific RASs, respectively. Among treatment-experienced genotype 1a patients, SVR rates were 76% (22/29) vs. 97% (409/420) for those with and without ledipasvir-specific RASs, respectively. Among treatment-naïve genotype 1b patients, SVR rates were 99% for both those with and without ledipasvir-specific RASs (71/72 vs. 331/334), and among treatment-experienced genotype 1b patients, SVR rates were 89% (41/46) vs. 98% (267/272) for those with and without ledipasvir-specific RASs, respectively. Conclusions Pretreatment ledipasvir-specific RASs that were present in 8–16% of patients have an impact on treatment outcome in some patient groups, particularly treatment-experienced patients with genotype 1a HCV. Lay summary The efficacy of treatments using NS5A inhibitors for patients with chronic hepatitis C virus (HCV) infection can be affected by the presence of NS5A resistance-associated substitutions (RASs). We reviewed results from 35 clinical trials where patients with genotype 1 HCV infection received treatments that included ledipasvir-sofosbuvir to determine how prevalent NS5A RASs are in patients at baseline, and found that ledipasvir-specific RASs were present in 8–16% of patients prior to treatment and had a negative impact on treatment outcome in subset of patient groups, particularly treatment-experienced patients with genotype 1a HCV

Comprehensive Analysis and Evaluation of Fukushima Daiichi Nuclear Power Station Unit 2

Estimation and understanding of the state of the fuel debris and fission products inside the plant comprise an essential step in the decommissioning of Tokyo Electric Power Company Holdings’ Fukushima Daiichi nuclear power station (1F). However, because of the plant’s high-radiation environment, direct observation of the plant interior is difficult. Therefore, in order to understand the plant’s interior conditions, comprehensive analysis and evaluation based on various measurement data from the plant, analysis of plant data during the accident progression phase, and information obtained from computer simulations for this phase are necessary. These evaluations can be used to estimate the conditions of the interior of the reactor pressure vessel (RPV) and the primary containment vessel (PCV). This paper addresses 1F Unit 2 as the subject to produce an estimated map of the fuel debris distribution from data obtained about the RPV and PCV based on comprehensive evaluation of various measurement data and information obtained from the accident progression analysis, which were released to the public in June 2018

Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance

ArticleLIVER INTERNATIONAL. 26(1): 90-96 (2006)journal articl

Review of Fukushima Daiichi Nuclear Power Station debris endstate location in OECD/NEA preparatory study on analysis of fuel debris (PreADES) project

Much is still not known about the end-state of core materials in each of the units at Fukushima Daiichi Nuclear Power Station (Daiichi) that were operating on March 11, 2011. The Nuclear Energy Agency of the Organization for Economic Development has launched the Preparatory Study on Analysis of Fuel Debris (PreADES) project as a first step to reduce some of these uncertainties. As part of the PreADES Task 1, relevant information was reviewed to confirm the accuracy of graphical depictions of the debris endstates at the damaged Daiichi units, which provides a basis for suggesting future debris examinations. Two activities have been completed within the PreADES Task 1. First, relevant knowledge from severe accidents at the Three Mile Island Unit 2 and the Chernobyl Nuclear Power Plant Unit 4 was reviewed, along with results from prototypic tests and hot cell examinations, to glean insights that may inform future decommissioning activities at Daiichi. Second, the current debris endstate diagrams for the damaged reactors at Daiichi were reviewed to confirm that they incorporate relevant knowledge from plant observations and from severe accident code analyses of the BSAF (Benchmark Study of the Accident at the Fukushima Daiichi Nuclear Power Station) 1 and 2 projects. This paper highlights Task 1 insights, which have the potential to not only inform future Decontamination and Decommissioning activities at Daiichi but also provide important perspectives for severe accident analyses and management, particularly regarding the long-term management of a damaged nuclear site following a severe accident